{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:12:19Z","timestamp":1763968339950,"version":"3.37.3"},"reference-count":39,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Polish Ministry of Science & Higher Education","award":["N N402 430039"],"award-info":[{"award-number":["N N402 430039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00005-019-00549-2","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T13:02:28Z","timestamp":1559998948000},"page":"311-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diverse Activity of IL-17+ Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease"],"prefix":"10.2478","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6590-4420","authenticated-orcid":false,"given":"Aleksandra","family":"Klimczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Suchnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariola","family":"Sedzimirska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2019,6,8]]},"reference":[{"key":"549_CR1","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato F, Cosmi L, Santarlasci V et al (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204:1849\u20131861","journal-title":"J Exp Med"},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbmt.2015.10.018","volume":"22","author":"M Arora","year":"2016","unstructured":"Arora M, Cutler CS, Jagasia MH et al (2016) Late acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 22:449\u2013455","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR3","first-page":"391","volume":"20","author":"KE Asigbetse","year":"2010","unstructured":"Asigbetse KE, Eigenmann PA, Frossard CP (2010) Intestinal lamina propria TcRgammadelta+ lymphocytes selectively express IL-10 and IL-17. J Investig Allergol Clin Immunol 20:391\u2013401","journal-title":"J Investig Allergol Clin Immunol"},{"key":"549_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.coi.2011.11.002","volume":"23","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Honda K (2011) Microbiota in autoimmunity and tolerance. Curr Opin Immunol 23:761\u2013768","journal-title":"Curr Opin Immunol"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbmt.2012.11.018","volume":"19","author":"F Bahr","year":"2013","unstructured":"Bahr F, Wehner R, Platzbecker U et al (2013) Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 19:357\u2013365","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175\u2013181","journal-title":"N Engl J Med"},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10875-010-9368-7","volume":"30","author":"C Blaschitz","year":"2010","unstructured":"Blaschitz C, Raffatellu M (2010) Th17 cytokines and the gut mucosal barrier. J Clin Immunol 30:196\u2013203","journal-title":"J Clin Immunol"},{"key":"549_CR8","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1182\/blood-2010-07-295436","volume":"116","author":"R Broady","year":"2010","unstructured":"Broady R, Yu J, Chow V et al (2010) Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood 116:5748\u20135751","journal-title":"Blood"},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1182\/blood-2013-07-514372","volume":"123","author":"MC Bruggen","year":"2014","unstructured":"Bruggen MC, Klein I, Greinix H et al (2014) Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease. Blood 123:290\u2013299","journal-title":"Blood"},{"key":"549_CR10","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1182\/blood-2007-05-091074","volume":"110","author":"X Chen","year":"2007","unstructured":"Chen X, Vodanovic-Jankovic S, Johnson B et al (2007) Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 110:3804\u20133813","journal-title":"Blood"},{"key":"549_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.coi.2010.06.008","volume":"22","author":"H Chung","year":"2010","unstructured":"Chung H, Kasper DL (2010) Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol 22:455\u2013460","journal-title":"Curr Opin Immunol"},{"key":"549_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2567.2012.03588.x","volume":"136","author":"BH Chung","year":"2012","unstructured":"Chung BH, Oh HJ, Piao SG et al (2012) Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection. Immunology 136:344\u2013351","journal-title":"Immunology"},{"key":"549_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/TP.0b013e3181bc267e","volume":"88","author":"E Dander","year":"2009","unstructured":"Dander E, Balduzzi A, Zappa G et al (2009) Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 88:1261\u20131272","journal-title":"Transplantation"},{"key":"549_CR14","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1016\/j.transproceed.2010.07.026","volume":"42","author":"D Dlubek","year":"2010","unstructured":"Dlubek D, Turlej E, Sedzimirska M et al (2010) Interleukin-17-producing cells increase among CD4+ lymphocytes before overt manifestation of acute graft-versus-host disease. Transplant Proc 42:3277\u20133279","journal-title":"Transplant Proc"},{"key":"549_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945\u2013956","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino S, Andoh A, Bamba S et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65\u201370","journal-title":"Gut"},{"key":"549_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1182\/bloodadvances.2016002980","volume":"1","author":"KH Gartlan","year":"2017","unstructured":"Gartlan KH, Varelias A, Koyama M et al (2017) Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT. Blood Adv 1:341\u2013351","journal-title":"Blood Adv"},{"key":"549_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm.2391","volume":"17","author":"K Geddes","year":"2011","unstructured":"Geddes K, Rubino SJ, Magalhaes JG et al (2011) Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17:837\u2013844","journal-title":"Nat Med"},{"key":"549_CR19","first-page":"15","volume":"15","author":"A Gigante","year":"2011","unstructured":"Gigante A, Gasperini ML, Afeltra A et al (2011) Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci 15:15\u201324","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"549_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1182\/blood-2009-11-256495","volume":"116","author":"GR Hill","year":"2010","unstructured":"Hill GR, Olver SD, Kuns RD et al (2010) Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood 116:819\u2013828","journal-title":"Blood"},{"key":"549_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M et al (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21:389\u2013401.e1","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1749-6632.1995.tb32360.x","volume":"762","author":"L Karabon","year":"1995","unstructured":"Karabon L, Moniewska A, Laba A et al (1995) IL-6 is present in sera of bone marrow-transplanted patients in aplastic period and high levels of IL-6 during acute graft-versus-host disease are associated with severe gut symptoms. Ann NY Acad Sci 762:439\u2013442","journal-title":"Ann NY Acad Sci"},{"key":"549_CR23","doi-asserted-by":"publisher","first-page":"960280","DOI":"10.1155\/2012\/960280","volume":"2012","author":"A Klimczak","year":"2012","unstructured":"Klimczak A, Lange A (2012) Th17 mediated alloreactivity is facilitated by the pre-transplant microbial burden of the recipient. Bone Marrow Res 2012:960280","journal-title":"Bone Marrow Res"},{"key":"549_CR24","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2169\/internalmedicine.55.6206","volume":"55","author":"S Koh","year":"2016","unstructured":"Koh S, Koh H, Nakashima Y et al (2016) Plasma kinetics of Th1, Th2 and Th17 cytokines in polymyositis related to chronic graft-versus-host disease. Intern Med 55:2265\u20132270","journal-title":"Intern Med"},{"key":"549_CR25","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.bbmt.2010.05.001","volume":"16","author":"D Liu","year":"2010","unstructured":"Liu D, Yan C, Xu L et al (2010) Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines. Biol Blood Marrow Transplant 16:1567\u20131575","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bbmt.2013.06.013","volume":"19","author":"Y Liu","year":"2013","unstructured":"Liu Y, Cai Y, Dai L et al (2013) The expression of Th17-associated cytokines in human acute graft-versus-host disease. Biol Blood Marrow Transplant 19:1421\u20131429","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","volume":"129","author":"KP MacDonald","year":"2017","unstructured":"MacDonald KP, Hill GR, Blazar BR (2017) Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood 129:13\u201321","journal-title":"Blood"},{"key":"549_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/bmt.2013.215","volume":"49","author":"F Malard","year":"2014","unstructured":"Malard F, Bossard C, Brissot E et al (2014) Increased Th17\/Treg ratio in chronic liver GVHD. Bone Marrow Transplant 49:539\u2013544","journal-title":"Bone Marrow Transplant"},{"key":"549_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/intimm\/13.1.95","volume":"13","author":"T Nakayama","year":"2001","unstructured":"Nakayama T, Fujisawa R, Yamada H et al (2001) Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)\/macrophage inflammatory protein (MIP)-3 alpha\/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13:95\u2013103","journal-title":"Int Immunol"},{"key":"549_CR30","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2009-12-255810","volume":"116","author":"P Ratajczak","year":"2010","unstructured":"Ratajczak P, Janin A, Peffault de Latour R et al (2010) Th17\/Treg ratio in human graft-versus-host disease. Blood 116:1165\u20131171","journal-title":"Blood"},{"key":"549_CR31","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","volume":"107","author":"K Rieger","year":"2006","unstructured":"Rieger K, Loddenkemper C, Maul J et al (2006) Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107:1717\u20131723","journal-title":"Blood"},{"key":"549_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T et al (2008) Regulatory T cells and immune tolerance. Cell 133:775\u2013787","journal-title":"Cell"},{"key":"549_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","volume":"12","author":"HM Shulman","year":"2006","unstructured":"Shulman HM, Kleiner D, Lee SJ et al (2006) Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group report. Biol Blood Marrow Transplant 12:31\u201347","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","volume":"21","author":"HM Shulman","year":"2015","unstructured":"Shulman HM, Cardona DM, Greenson JK et al (2015) NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group report. Biol Blood Marrow Transplant 21:589\u2013603","journal-title":"Biol Blood Marrow Transplant"},{"key":"549_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4049\/jimmunol.180.1.214","volume":"180","author":"SP Singh","year":"2008","unstructured":"Singh SP, Zhang HH, Foley JF et al (2008) Human T cells that are able to produce IL-17 express the chemokine receptor CCR35. J Immunol 180:214\u2013221","journal-title":"J Immunol"},{"key":"549_CR36","doi-asserted-by":"publisher","first-page":"e50896","DOI":"10.1371\/journal.pone.0050896","volume":"7","author":"AB van der Waart","year":"2012","unstructured":"van der Waart AB, van der Velden WJ, van Halteren AG et al (2012) Decreased levels of circulating IL17-producing CD161+ CCR36+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation. PLoS One 7:e50896","journal-title":"PLoS One"},{"key":"549_CR37","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2014-07-590232","volume":"125","author":"A Varelias","year":"2015","unstructured":"Varelias A, Gartlan KH, Kreijveld E et al (2015) Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood 125:2435\u20132444","journal-title":"Blood"},{"key":"549_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/mi.2008.84","volume":"2","author":"C Wang","year":"2009","unstructured":"Wang C, Kang SG, Lee J et al (2009) The roles of CCR38 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2:173\u2013183","journal-title":"Mucosal Immunol"},{"key":"549_CR39","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","volume":"106","author":"E Zorn","year":"2005","unstructured":"Zorn E, Kim HT, Lee SJ et al (2005) Reduced frequency of FOXP3+ CD4+ CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106:2903\u20132911","journal-title":"Blood"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-019-00549-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:17Z","timestamp":1704228557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-019-00549-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,8]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s00005-019-00549-2","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"type":"print","value":"0004-069X"},{"type":"electronic","value":"1661-4917"}],"subject":[],"published":{"date-parts":[[2019,6,8]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}